Tether, a leading stablecoin issuer, has made a groundbreaking $200M investment in Blackrock Neurotech, a firm at the cutting edge of brain-computer interface (BCI) technology and a direct competitor to Elon Musk’s Neuralink. This strategic move by Tether Evo, Tether’s venture division, signals a significant expansion beyond stablecoins into neuroscience and neural prosthetics, areas pioneered by Blackrock Neurotech since its inception in 2008.
Blackrock Neurotech’s commitment to alleviating neurological disorders and enhancing mobility for millions sets it apart, with the investment poised to accelerate innovations in BCI technology. This partnership not only bolsters Blackrock Neurotech’s mission but also highlights Tether’s diversification into sectors such as data, education, and power, marking a pivotal shift in the global crypto landscape.
At press time, this collaboration has contributed to a 22.62% surge in Tether’s 24-hour trading volume, showcasing the market’s positive reception to the venture.
This strategic collaboration underscores Tether’s ambition to pioneer beyond the realm of digital currency, positioning it at the forefront of technological advancements in neuroscience and neural engineering.
